EVEROLIMUS TABLETS

EVEROLIMUS TABLETS was reported 17092 times

EVEROLIMUS TABLETS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VOCAL FOLD IMMOBILITY 13 0.6842
1 GRANULOMATOUS ROSACEA 14 0.2857
2 BIPHASIC MESOTHELIOMA 11 0.2558
3 ADENOVIRUS INTERSTITIAL NEPHRITIS 14 0.2500
4 ACANTHOMA 10 0.1923
5 ACCIDENTAL EXPOSURE TO PRODUCT PACKAGING 42 0.1772
6 POLYOMAVIRUS VIRAEMIA 182 0.1714
7 PIK3CA-ACTIVATED MUTATION 56 0.1687
8 ISOSPORIASIS 12 0.1538
9 POLYOMAVIRUS TEST POSITIVE 18 0.1525
10 BRAIN STEM GLIOMA 23 0.1513
11 HEPATIC ANGIOSARCOMA 10 0.1370
12 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 308 0.1313
13 VASCULAR HYALINOSIS 11 0.1294
14 INSULINOMA 21 0.1186
15 CARCINOID TUMOUR PULMONARY 26 0.1079
16 CHORDOMA 10 0.0971
17 MICROSPORIDIA INFECTION 34 0.0969
18 CONGENITAL CORONARY ARTERY MALFORMATION 16 0.0947
19 PLEURAL NEOPLASM 15 0.0909
20 MYCOBACTERIUM HAEMOPHILUM INFECTION 26 0.0909
21 VIRAEMIA 125 0.0902
22 BK VIRUS INFECTION 299 0.0886
23 HUMAN POLYOMAVIRUS INFECTION 47 0.0885
24 PANCREATIC NEUROENDOCRINE TUMOUR 55 0.0858
25 HORMONE RECEPTOR POSITIVE BREAST CANCER 23 0.0846
26 COMPLICATIONS OF TRANSPLANTED HEART 18 0.0837
27 CYTOMEGALOVIRUS GASTRITIS 21 0.0830
28 BLOOD GASTRIN INCREASED 10 0.0781
29 METASTASES TO SKIN 74 0.0716
30 PNEUMONIA ADENOVIRAL 14 0.0707
31 CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION 21 0.0705
32 PSEUDOCIRRHOSIS 22 0.0663
33 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 77 0.0642
34 POST TRANSPLANT DISTAL LIMB SYNDROME 13 0.0640
35 ADENOVIRAL HEPATITIS 15 0.0638
36 BLOOD CHROMOGRANIN A INCREASED 28 0.0610
37 PARVOVIRUS B19 INFECTION 54 0.0603
38 PANCREATIC STEATOSIS 16 0.0588
39 PANCREATIC NEUROENDOCRINE TUMOUR METASTATIC 14 0.0586
40 PARASITIC GASTROENTERITIS 11 0.0573
41 LYMPHOCELE 38 0.0572
42 METASTASES TO THE MEDIASTINUM 22 0.0534
43 ENTEROCOLITIS VIRAL 16 0.0526
44 CYTOMEGALOVIRUS GASTROENTERITIS 11 0.0509
45 HUMAN HERPESVIRUS 8 INFECTION 31 0.0509
46 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 259 0.0508
47 HERPES SIMPLEX HEPATITIS 12 0.0500
48 GASTRIC ANTRAL VASCULAR ECTASIA 26 0.0491
49 TRICHODYSPLASIA SPINULOSA 18 0.0472
50 HEART TRANSPLANT REJECTION 49 0.0472
51 LUNG TRANSPLANT REJECTION 31 0.0470
52 METASTASES TO SOFT TISSUE 12 0.0463
53 HEPATITIS E 73 0.0462
54 COMPLICATIONS OF TRANSPLANTED LUNG 14 0.0456
55 LIVER TRANSPLANT REJECTION 80 0.0445
56 NEUROENDOCRINE TUMOUR 63 0.0445
57 MALACOPLAKIA 20 0.0437
58 RENAL TRANSPLANT FAILURE 43 0.0435
59 COMPLICATIONS OF TRANSPLANTED KIDNEY 96 0.0423
60 TRANSPLANT REJECTION 329 0.0410
61 METASTASES TO PLEURA 43 0.0410
62 RENAL TUBULAR ATROPHY 36 0.0408
63 MUCOSAL TOXICITY 11 0.0406
64 DELAYED GRAFT FUNCTION 28 0.0394
65 METASTASES TO BREAST 13 0.0392
66 CHRONIC ALLOGRAFT NEPHROPATHY 30 0.0383
67 PNEUMOCYSTIS JIROVECII INFECTION 44 0.0368
68 HORMONE RECEPTOR POSITIVE HER2 NEGATIVE BREAST CANCER 12 0.0361
69 METASTASES TO PANCREAS 16 0.0361
70 ANGIOSARCOMA 16 0.0347
71 METASTASES TO HEART 10 0.0331
72 ALVEOLAR PROTEINOSIS 19 0.0321
73 WEST NILE VIRAL INFECTION 24 0.0320
74 EPSTEIN-BARR VIRAEMIA 35 0.0316
75 PNEUMONITIS CHEMICAL 11 0.0315
76 KIDNEY FIBROSIS 54 0.0311
77 SMOOTH MUSCLE CELL NEOPLASM 13 0.0311
78 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 18 0.0305
79 CARBOHYDRATE ANTIGEN 15-3 INCREASED 23 0.0302
80 CYTOMEGALOVIRUS OESOPHAGITIS 11 0.0299
81 ENDOMETRIAL ADENOCARCINOMA 19 0.0299
82 MEDIASTINAL DISORDER 11 0.0294
83 METASTASES TO LIVER 517 0.0294
84 CLEAR CELL RENAL CELL CARCINOMA 20 0.0287
85 KIDNEY TRANSPLANT REJECTION 137 0.0285
86 METASTASES TO LYMPH NODES 192 0.0284
87 METASTASES TO BONE 466 0.0284
88 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 93 0.0281
89 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 36 0.0273
90 INVASIVE LOBULAR BREAST CARCINOMA 14 0.0273
91 ANAL ULCER 22 0.0269
92 METASTASES TO LUNG 309 0.0267
93 METASTASES TO SPLEEN 11 0.0266
94 THROMBOTIC MICROANGIOPATHY 259 0.0266
95 BREAST CANCER METASTATIC 271 0.0252
96 METASTATIC RENAL CELL CARCINOMA 46 0.0251
97 METASTASES TO ABDOMINAL CAVITY 12 0.0244
98 TRANSPLANT DYSFUNCTION 42 0.0235
99 GRAFT LOSS 17 0.0234
100 ABDOMINAL LYMPHADENOPATHY 20 0.0230
101 HYDROTHORAX 19 0.0229
102 EPSTEIN-BARR VIRUS INFECTION 143 0.0229
103 CRYPTOSPORIDIOSIS INFECTION 12 0.0229
104 METASTASES TO PERITONEUM 57 0.0225
105 BILE DUCT STENOSIS 27 0.0225
106 PLEURAL DISORDER 14 0.0223
107 CYTOMEGALOVIRUS COLITIS 51 0.0222
108 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED 13 0.0219
109 LYMPHANGIOSIS CARCINOMATOSA 22 0.0211
110 METASTASES TO SPINE 69 0.0205
111 JC VIRUS INFECTION 32 0.0200
112 SEROSITIS 11 0.0199
113 CYTOMEGALOVIRUS INFECTION 328 0.0197
114 ENCEPHALITIS VIRAL 24 0.0197
115 BONE LESION 70 0.0194
116 CORYNEBACTERIUM INFECTION 10 0.0187
117 METASTASES TO PELVIS 11 0.0174
118 HAEMOLYTIC URAEMIC SYNDROME 40 0.0172
119 NODULAR REGENERATIVE HYPERPLASIA 11 0.0171
120 TRANSITIONAL CELL CARCINOMA 22 0.0169
121 PNEUMONITIS 453 0.0166
122 PNEUMONIA CYTOMEGALOVIRAL 32 0.0165
123 VARICELLA ZOSTER VIRUS INFECTION 34 0.0164
124 PNEUMONIA PSEUDOMONAL 25 0.0163
125 HEPATIC LESION 70 0.0162
126 TUMOUR NECROSIS 17 0.0161
127 CONCOMITANT DISEASE PROGRESSION 31 0.0158
128 CYTOMEGALOVIRUS TEST POSITIVE 28 0.0157
129 LYMPHADENOPATHY MEDIASTINAL 30 0.0156
130 MALIGNANT NEOPLASM PROGRESSION 1592 0.0155
131 CHYLOTHORAX 11 0.0153
132 NOROVIRUS INFECTION 22 0.0152
133 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 12 0.0152
134 OESOPHAGITIS ULCERATIVE 10 0.0146
135 TUMOUR MARKER INCREASED 70 0.0146
136 ANOGENITAL WARTS 13 0.0146
137 ADENOVIRUS INFECTION 42 0.0145
138 PULMONARY SEPSIS 21 0.0144
139 SQUAMOUS CELL CARCINOMA OF SKIN 87 0.0144
140 ACTINIC KERATOSIS 37 0.0142
141 INFECTION REACTIVATION 16 0.0140
142 PYELONEPHRITIS ACUTE 27 0.0138
143 TUMOUR PAIN 18 0.0137
144 CARCINOID TUMOUR 10 0.0134
145 CYTOMEGALOVIRUS INFECTION REACTIVATION 59 0.0133
146 HYPERTRIGLYCERIDAEMIA 78 0.0133
147 REFLUX GASTRITIS 16 0.0133
148 IGA NEPHROPATHY 22 0.0133
149 CHOLANGITIS ACUTE 10 0.0132
150 RENAL CELL CARCINOMA 64 0.0131
151 CHOLANGITIS 81 0.0131
152 DIFFUSE ALVEOLAR DAMAGE 15 0.0130
153 SINUS ARRHYTHMIA 17 0.0130
154 METASTASES TO ADRENALS 12 0.0130
155 ORGANISING PNEUMONIA 64 0.0129
156 ILEAL ULCER 13 0.0128
157 CHRONIC GRAFT VERSUS HOST DISEASE 46 0.0127
158 ENDOCARDITIS BACTERIAL 10 0.0127
159 STENOTROPHOMONAS INFECTION 17 0.0125
160 LYMPHANGITIS 10 0.0124
161 ESCHERICHIA SEPSIS 36 0.0124
162 CYTOMEGALOVIRUS VIRAEMIA 55 0.0124
163 RENAL TUBULAR INJURY 15 0.0123
164 SYSTEMIC MYCOSIS 14 0.0120
165 INVASIVE DUCTAL BREAST CARCINOMA 32 0.0118
166 HEPATIC CANCER METASTATIC 10 0.0117
167 PAPILLOMA VIRAL INFECTION 19 0.0115
168 OESOPHAGEAL OBSTRUCTION 10 0.0115
169 TONIC CONVULSION 16 0.0113
170 PYURIA 11 0.0111
171 COMA SCALE ABNORMAL 32 0.0110
172 NEPHROPATHY TOXIC 123 0.0109
173 DYSPLASIA 13 0.0108
174 DYSLIPIDAEMIA 55 0.0108
175 MUCOSAL INFLAMMATION 281 0.0107
176 MALIGNANT PLEURAL EFFUSION 18 0.0107
177 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 17 0.0106
178 CELL DEATH 21 0.0106
179 LIVER ABSCESS 34 0.0105
180 PROTEINURIA 196 0.0103
181 NORMOCYTIC ANAEMIA 15 0.0102
182 HAEMOPHILUS INFECTION 10 0.0102
183 APHTHOUS ULCER 79 0.0102
184 INCISIONAL HERNIA 14 0.0101
185 PNEUMOCYSTIS JIROVECII PNEUMONIA 101 0.0100
186 LUNG CONSOLIDATION 28 0.0100
187 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 21 0.0099
188 VASCULAR STENT THROMBOSIS 20 0.0098
189 BREAST CANCER RECURRENT 31 0.0098
190 KLEBSIELLA SEPSIS 11 0.0098
191 LARGE INTESTINE INFECTION 12 0.0098
192 ENTEROCOCCAL INFECTION 46 0.0095
193 ARTERIAL THROMBOSIS 18 0.0093
194 RENAL TUBULAR NECROSIS 91 0.0093
195 METASTASES TO MENINGES 21 0.0092
196 URINARY TRACT INFECTION BACTERIAL 23 0.0091
197 TRANSPLANT FAILURE 22 0.0090
198 METASTASIS 63 0.0088
199 CANCER PAIN 22 0.0086
200 GENE MUTATION 17 0.0086
201 HAEMATOLOGICAL INFECTION 21 0.0086
202 BILIARY OBSTRUCTION 11 0.0085
203 NORMOCHROMIC NORMOCYTIC ANAEMIA 25 0.0083
204 EXPOSED BONE IN JAW 18 0.0083
205 DISSEMINATED TUBERCULOSIS 21 0.0082
206 DRUG LEVEL INCREASED 135 0.0081
207 CHOLANGIOCARCINOMA 12 0.0081
208 STRONGYLOIDIASIS 13 0.0080
209 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 60 0.0080
210 KLEBSIELLA INFECTION 40 0.0079
211 STOMATITIS 473 0.0078
212 BRONCHOPULMONARY ASPERGILLOSIS 60 0.0077
213 LUNG INFILTRATION 68 0.0077
214 SOFT TISSUE INFECTION 14 0.0076
215 HEPATITIS B REACTIVATION 24 0.0076
216 ODYNOPHAGIA 45 0.0075
217 HYPOPHOSPHATAEMIA 55 0.0074
218 SKIN TOXICITY 42 0.0074
219 CRYPTOCOCCOSIS 12 0.0074
220 ESCHERICHIA URINARY TRACT INFECTION 31 0.0073
221 HEPATIC MASS 14 0.0073
222 APLASIA PURE RED CELL 25 0.0073
223 CARCINOEMBRYONIC ANTIGEN INCREASED 14 0.0072
224 ENTEROBACTER INFECTION 12 0.0071
225 PSEUDOMONAS INFECTION 61 0.0071
226 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 10 0.0071
227 BACTERIAL SEPSIS 23 0.0071
228 HYPERCHOLESTEROLAEMIA 68 0.0070
229 COVID-19 PNEUMONIA 82 0.0069
230 PAPILLARY THYROID CANCER 12 0.0069
231 ESCHERICHIA INFECTION 56 0.0068
232 BILIARY DILATATION 10 0.0068
233 SYSTEMIC CANDIDA 17 0.0068
234 RESPIRATORY ALKALOSIS 11 0.0068
235 LYMPHOEDEMA 46 0.0066
236 ENCEPHALITIS 46 0.0066
237 VENA CAVA THROMBOSIS 11 0.0066
238 VACCINATION FAILURE 11 0.0066
239 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 154 0.0066
240 OSTEONECROSIS OF JAW 163 0.0066
241 ENTERITIS 42 0.0066
242 MULTIPLE ORGAN DYSFUNCTION SYNDROME 185 0.0065
243 AMYLASE INCREASED 24 0.0065
244 PORTAL HYPERTENSION 20 0.0065
245 HEPATOCELLULAR CARCINOMA 49 0.0064
246 CACHEXIA 33 0.0064
247 DISEASE PROGRESSION 758 0.0064
248 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 61 0.0064
249 PLEURAL EFFUSION 388 0.0064
250 MOUTH ULCERATION 134 0.0064
251 HUMAN HERPESVIRUS 6 INFECTION 12 0.0063
252 DRUG LEVEL DECREASED 64 0.0063
253 METASTASES TO CENTRAL NERVOUS SYSTEM 81 0.0063
254 HYDRONEPHROSIS 47 0.0063
255 ASPERGILLUS INFECTION 41 0.0062
256 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 11 0.0062
257 NEOPLASM PROGRESSION 214 0.0061
258 BLOOD CREATININE ABNORMAL 21 0.0061
259 ASCITES 178 0.0060
260 NEUROLOGICAL DECOMPENSATION 14 0.0060
261 METASTATIC NEOPLASM 26 0.0060
262 PNEUMONIA KLEBSIELLA 11 0.0060
263 BACTERIAL INFECTION 111 0.0059
264 GRAFT VERSUS HOST DISEASE IN SKIN 13 0.0059
265 CARDIOPULMONARY FAILURE 23 0.0059
266 CYTOPENIA 72 0.0059
267 LYMPHOPENIA 83 0.0059
268 INTERSTITIAL LUNG DISEASE 282 0.0058
269 DRUG RESISTANCE 149 0.0058
270 HAEMATOTOXICITY 55 0.0058
271 MENINGITIS CRYPTOCOCCAL 10 0.0057
272 LUNG ADENOCARCINOMA 17 0.0056
273 RECURRENT CANCER 23 0.0056
274 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 11 0.0056
275 LARGE INTESTINAL ULCER 15 0.0055
276 PULMONARY TOXICITY 39 0.0055
277 ACUTE RESPIRATORY DISTRESS SYNDROME 97 0.0055
278 DEVICE RELATED SEPSIS 11 0.0055
279 DIFFUSE LARGE B-CELL LYMPHOMA 42 0.0054
280 STRIDOR 16 0.0054
281 PYELONEPHRITIS 47 0.0054
282 GRAFT VERSUS HOST DISEASE 39 0.0054
283 UROSEPSIS 50 0.0054
284 RENAL IMPAIRMENT 454 0.0054
285 RALES 31 0.0053
286 PNEUMONIA VIRAL 17 0.0053
287 PNEUMONIA FUNGAL 21 0.0053
288 LUNG OPACITY 14 0.0053
289 OESOPHAGEAL ULCER 20 0.0052
290 APHTHOUS STOMATITIS 12 0.0052
291 PERFORMANCE STATUS DECREASED 24 0.0051
292 PATHOLOGICAL FRACTURE 26 0.0051
293 NEPHROTIC SYNDROME 35 0.0051
294 GASTROINTESTINAL TOXICITY 24 0.0050
295 PORTAL VEIN THROMBOSIS 16 0.0049
296 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 13 0.0049
297 LEUKOPENIA 244 0.0049
298 PERICARDIAL EFFUSION 112 0.0048
299 SHOCK HAEMORRHAGIC 39 0.0048
300 BRAIN ABSCESS 12 0.0047
301 HYPERGLYCAEMIA 171 0.0047
302 SEPTIC SHOCK 204 0.0047
303 PNEUMONIA BACTERIAL 43 0.0047
304 HYPERURICAEMIA 19 0.0046
305 RENAL TUBULAR DISORDER 13 0.0046
306 DERMATITIS ACNEIFORM 28 0.0046
307 CHOLECYSTITIS ACUTE 26 0.0046
308 PANNICULITIS 11 0.0045
309 HYPERLIPIDAEMIA 54 0.0045
310 ENTEROCOLITIS 26 0.0045
311 GLOMERULONEPHRITIS 11 0.0045
312 THERAPY PARTIAL RESPONDER 70 0.0045
313 CYSTITIS HAEMORRHAGIC 18 0.0045
314 PULMONARY TUBERCULOSIS 19 0.0044
315 CHOLECYSTITIS INFECTIVE 12 0.0043
316 LARGE INTESTINE PERFORATION 30 0.0043
317 HERPES SIMPLEX 28 0.0043
318 PULMONARY MASS 64 0.0043
319 ACUTE PULMONARY OEDEMA 24 0.0043
320 ACUTE RESPIRATORY FAILURE 82 0.0043
321 SQUAMOUS CELL CARCINOMA 40 0.0042
322 FORCED EXPIRATORY VOLUME DECREASED 12 0.0042
323 ERYSIPELAS 21 0.0042
324 POTENTIATING DRUG INTERACTION 14 0.0042
325 GASTROINTESTINAL STROMAL TUMOUR 11 0.0041
326 HAEMOTHORAX 12 0.0041
327 PARONYCHIA 18 0.0041
328 GASTROINTESTINAL INJURY 11 0.0041
329 VENOUS THROMBOSIS 16 0.0041
330 BLOOD CREATININE INCREASED 265 0.0041
331 THORACIC VERTEBRAL FRACTURE 12 0.0041
332 BASAL CELL CARCINOMA 63 0.0040
333 OESOPHAGEAL CANDIDIASIS 16 0.0040
334 THYROIDITIS 12 0.0040
335 BONE MARROW DISORDER 12 0.0040
336 EMERGENCY CARE 12 0.0040
337 ABDOMINAL HERNIA 18 0.0039
338 ATELECTASIS 38 0.0039
339 DRUG LEVEL ABOVE THERAPEUTIC 18 0.0039
340 LIPASE INCREASED 30 0.0039
341 ENDOCARDITIS 20 0.0039
342 HYPERCALCAEMIA 48 0.0039
343 DRUG TITRATION ERROR 10 0.0039
344 THROMBOCYTOPENIA 433 0.0039
345 SKIN NECROSIS 20 0.0039
346 SPINAL CORD COMPRESSION 15 0.0038
347 BLOOD LACTATE DEHYDROGENASE INCREASED 61 0.0038
348 WOUND DEHISCENCE 13 0.0038
349 DUODENAL ULCER HAEMORRHAGE 11 0.0038
350 CONGESTIVE CARDIOMYOPATHY 16 0.0038
351 HYPOMAGNESAEMIA 53 0.0038
352 LEFT VENTRICULAR FAILURE 13 0.0038
353 NECROSIS 21 0.0038
354 PULMONARY ALVEOLAR HAEMORRHAGE 21 0.0037
355 GLOMERULAR FILTRATION RATE DECREASED 46 0.0037
356 JAUNDICE CHOLESTATIC 13 0.0037
357 HEPATIC NEOPLASM 12 0.0037
358 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 14 0.0037
359 HEPATITIS B 22 0.0036
360 MACULE 10 0.0036
361 CARDIAC TAMPONADE 17 0.0036
362 MULTIPLE-DRUG RESISTANCE 11 0.0035
363 DRUG INTERACTION 559 0.0035
364 PATHOGEN RESISTANCE 32 0.0035
365 AZOTAEMIA 14 0.0035
366 HEPATIC FIBROSIS 12 0.0035
367 ORAL PAIN 78 0.0035
368 ORGAN FAILURE 14 0.0035
369 PANCYTOPENIA 194 0.0035
370 ORTHOPNOEA 11 0.0035
371 DYSPNOEA AT REST 10 0.0034
372 SKIN MASS 23 0.0034
373 ACUTE KIDNEY INJURY 525 0.0034
374 LOOSE TOOTH 11 0.0034
375 BLOOD TRIGLYCERIDES INCREASED 60 0.0034
376 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 28 0.0034
377 HOSPICE CARE 33 0.0033
378 NEUROTOXICITY 58 0.0033
379 GASTROENTERITIS 48 0.0033
380 BLOOD UREA INCREASED 55 0.0033
381 FACIAL PARALYSIS 28 0.0033
382 IMMUNE THROMBOCYTOPENIA 15 0.0033
383 DUODENITIS 10 0.0033
384 GASTROINTESTINAL INFECTION 29 0.0032
385 PLEURISY 19 0.0032
386 ARTERIOSCLEROSIS 30 0.0032
387 RESPIRATORY FAILURE 231 0.0032
388 SPINAL PAIN 37 0.0032
389 BEHAVIOUR DISORDER 17 0.0031
390 ANURIA 27 0.0031
391 SECOND PRIMARY MALIGNANCY 26 0.0031
392 FIBRIN D DIMER INCREASED 11 0.0031
393 PNEUMOTHORAX 49 0.0031
394 DRUG LEVEL BELOW THERAPEUTIC 17 0.0031
395 CONCOMITANT DISEASE AGGRAVATED 19 0.0031
396 NEUTROPENIA 418 0.0031
397 PRODUCT USE IN UNAPPROVED INDICATION 755 0.0030
398 TUBULOINTERSTITIAL NEPHRITIS 57 0.0030
399 CHOLECYSTITIS 36 0.0030
400 COMPRESSION FRACTURE 16 0.0030
401 HEPATITIS C 36 0.0030
402 CHOLESTASIS 57 0.0030
403 NEOPLASM RECURRENCE 10 0.0029
404 BLOOD CREATINE INCREASED 13 0.0029
405 ENDOMETRIOSIS 14 0.0029
406 POLYNEUROPATHY 35 0.0029
407 TRANSAMINASES INCREASED 65 0.0029
408 GUILLAIN-BARRE SYNDROME 14 0.0029
409 ANAEMIA 549 0.0029
410 ERYTHEMA NODOSUM 10 0.0028
411 ACUTE GRAFT VERSUS HOST DISEASE 13 0.0028
412 LEFT VENTRICULAR DYSFUNCTION 19 0.0028
413 AORTIC VALVE INCOMPETENCE 12 0.0028
414 ELECTROLYTE IMBALANCE 32 0.0028
415 STATUS EPILEPTICUS 31 0.0027
416 BLOOD PHOSPHORUS DECREASED 10 0.0027
417 INTESTINAL ISCHAEMIA 15 0.0027
418 IMPAIRED HEALING 89 0.0027
419 SEPSIS 302 0.0027
420 HYPOALBUMINAEMIA 21 0.0027
421 HYPOCALCAEMIA 51 0.0027
422 ILEUS PARALYTIC 12 0.0027
423 MALNUTRITION 30 0.0027
424 CANDIDA INFECTION 45 0.0027
425 RENAL CYST 21 0.0026
426 BONE DISORDER 48 0.0026
427 DEHYDRATION 351 0.0026
428 HYPERVOLAEMIA 13 0.0026
429 HAEMOLYSIS 20 0.0026
430 HYPOXIA 91 0.0026
431 HYPOPHAGIA 66 0.0026
432 HEPATIC ENCEPHALOPATHY 24 0.0026
433 CORONAVIRUS INFECTION 17 0.0026
434 THERAPY NON-RESPONDER 115 0.0026
435 HYPOKALAEMIA 118 0.0026
436 CARDIAC FAILURE ACUTE 17 0.0025
437 POSTOPERATIVE WOUND INFECTION 17 0.0025
438 GENERALISED OEDEMA 31 0.0025
439 BLOOD URIC ACID INCREASED 14 0.0024
440 THERAPY INTERRUPTED 173 0.0024
441 AORTIC DISSECTION 10 0.0024
442 EMBOLISM 20 0.0024
443 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 12 0.0024
444 METABOLIC ACIDOSIS 77 0.0024
445 GENERAL PHYSICAL HEALTH DETERIORATION 277 0.0024
446 LOW BIRTH WEIGHT BABY 19 0.0024
447 CORONARY ARTERY STENOSIS 12 0.0024
448 HYDROCEPHALUS 13 0.0024
449 IMMUNOSUPPRESSION 21 0.0024
450 LOCALISED OEDEMA 11 0.0024
451 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 12 0.0024
452 PERITONITIS 49 0.0024
453 ACIDOSIS 18 0.0024
454 GAMMA-GLUTAMYLTRANSFERASE INCREASED 52 0.0023
455 HEPATIC PAIN 10 0.0023
456 THERAPY CHANGE 23 0.0023
457 ECCHYMOSIS 16 0.0023
458 SKIN LESION 64 0.0023
459 MYOPATHY 20 0.0023
460 HYPERTRANSAMINASAEMIA 16 0.0023
461 BRAIN OEDEMA 29 0.0023
462 COAGULOPATHY 38 0.0023
463 BACTERAEMIA 27 0.0023
464 ATAXIA 27 0.0023
465 PAPULE 16 0.0023
466 ABDOMINAL ABSCESS 10 0.0023
467 BREAST CANCER 210 0.0023
468 CARDIOMYOPATHY 33 0.0022
469 IRON DEFICIENCY 10 0.0022
470 TOXICITY TO VARIOUS AGENTS 374 0.0022
471 MYELODYSPLASTIC SYNDROME 32 0.0022
472 PROTEIN URINE PRESENT 11 0.0022
473 BLOOD MAGNESIUM DECREASED 19 0.0022
474 WOUND INFECTION 24 0.0022
475 HYPERKERATOSIS 12 0.0022
476 C-REACTIVE PROTEIN INCREASED 79 0.0022
477 BONE MARROW FAILURE 44 0.0022
478 COLITIS 82 0.0022
479 BLOOD PRESSURE SYSTOLIC INCREASED 42 0.0022
480 LYMPHOCYTE COUNT DECREASED 38 0.0021
481 PHLEBITIS 11 0.0021
482 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 13 0.0021
483 LUNG INFECTION 33 0.0021
484 SMALL INTESTINAL OBSTRUCTION 26 0.0021
485 HAEMODYNAMIC INSTABILITY 16 0.0021
486 LIVER FUNCTION TEST ABNORMAL 61 0.0021
487 OLIGURIA 13 0.0021
488 BLOOD ALKALINE PHOSPHATASE INCREASED 52 0.0021
489 CARDIAC FAILURE 168 0.0021
490 LUNG DISORDER 102 0.0021
491 DECREASED APPETITE 483 0.0021
492 DYSPNOEA EXERTIONAL 78 0.0021
493 MUSCULOSKELETAL CHEST PAIN 32 0.0021
494 METABOLIC DISORDER 12 0.0021
495 HEPATIC FUNCTION ABNORMAL 77 0.0021
496 URINE OUTPUT DECREASED 18 0.0021
497 BLOOD CALCIUM INCREASED 18 0.0021
498 HYPOVOLAEMIA 12 0.0020
499 ACUTE HEPATIC FAILURE 28 0.0020
500 OEDEMA 111 0.0020
501 OEDEMA PERIPHERAL 249 0.0020
502 NEPHROPATHY 19 0.0020
503 RESPIRATORY TRACT INFECTION 53 0.0020
504 LIVER DISORDER 90 0.0020
505 HEPATIC FAILURE 61 0.0020
506 TASTE DISORDER 41 0.0020
507 HYPOGLYCAEMIA 98 0.0020
508 BLOOD SODIUM DECREASED 38 0.0020
509 HYPERNATRAEMIA 10 0.0020
510 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 110 0.0020
511 ACUTE MYELOID LEUKAEMIA 31 0.0020
512 RENAL FAILURE 264 0.0020
513 DUODENAL ULCER 14 0.0020
514 UPPER GASTROINTESTINAL HAEMORRHAGE 33 0.0020
515 FISTULA 22 0.0020
516 HAEMATURIA 67 0.0020
517 RESPIRATORY SYNCYTIAL VIRUS INFECTION 17 0.0020
518 CARDIOMEGALY 24 0.0019
519 SKIN CANCER 42 0.0019
520 DEVICE RELATED INFECTION 30 0.0019
521 HEMIPARESIS 33 0.0019
522 ORAL HERPES 38 0.0019
523 FEBRILE NEUTROPENIA 129 0.0019
524 DIARRHOEA 1255 0.0019
525 SKIN ULCER 50 0.0019
526 FLANK PAIN 18 0.0019
527 ASPIRATION 21 0.0019
528 APLASTIC ANAEMIA 10 0.0019
529 NEOPLASM 22 0.0019
530 TACHYPNOEA 26 0.0019
531 ORAL CANDIDIASIS 25 0.0019
532 GINGIVAL PAIN 15 0.0019
533 RESPIRATORY DISTRESS 52 0.0019
534 PNEUMONIA 609 0.0019
535 EJECTION FRACTION DECREASED 29 0.0019
536 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 11 0.0019
537 ANAL ABSCESS 10 0.0019
538 BREAST CANCER STAGE III 12 0.0019
539 PYREXIA 640 0.0018
540 POLYURIA 15 0.0018
541 EATING DISORDER 39 0.0018
542 HYPONATRAEMIA 103 0.0018
543 BONE PAIN 107 0.0018
544 TYPE 1 DIABETES MELLITUS 11 0.0018
545 APPENDICITIS 17 0.0018
546 HYPOTHYROIDISM 58 0.0018
547 SPINAL COMPRESSION FRACTURE 15 0.0018
548 FOLLICULITIS 19 0.0018
549 DIABETES MELLITUS 138 0.0018
550 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 16 0.0018
551 ANGIOEDEMA 80 0.0018
552 MYELOSUPPRESSION 65 0.0018
553 MULTI-ORGAN FAILURE 31 0.0018
554 HAEMOPTYSIS 50 0.0018
555 ENCEPHALOPATHY 44 0.0018
556 HAEMOLYTIC ANAEMIA 16 0.0018
557 INTESTINAL PERFORATION 20 0.0018
558 ILEUS 22 0.0018
559 GENERAL PHYSICAL CONDITION ABNORMAL 12 0.0018
560 MITRAL VALVE INCOMPETENCE 20 0.0018
561 PULMONARY OEDEMA 79 0.0018
562 TRICUSPID VALVE INCOMPETENCE 14 0.0018
563 MYOCLONUS 21 0.0018
564 DRUG INTOLERANCE 169 0.0017
565 PULMONARY EMBOLISM 166 0.0017
566 CHOLELITHIASIS 57 0.0017
567 PANCREATITIS ACUTE 39 0.0017
568 RENAL FAILURE ACUTE 73 0.0017
569 HEPATITIS 44 0.0017
570 HAEMOGLOBIN ABNORMAL 11 0.0017
571 HEPATOTOXICITY 38 0.0017
572 HYPERTHERMIA 13 0.0017
573 EPILEPSY 52 0.0017
574 URINARY TRACT INFECTION 290 0.0017
575 CLOSTRIDIUM DIFFICILE COLITIS 18 0.0017
576 DIVERTICULUM 12 0.0017
577 JAUNDICE 45 0.0017
578 BLOOD POTASSIUM INCREASED 27 0.0017
579 HYPERTENSION 352 0.0017
580 ALANINE AMINOTRANSFERASE INCREASED 102 0.0017
581 HAEMATOMA 43 0.0017
582 ASPARTATE AMINOTRANSFERASE INCREASED 88 0.0017
583 HELICOBACTER INFECTION 17 0.0017
584 ADRENAL INSUFFICIENCY 20 0.0016
585 OESOPHAGITIS 18 0.0016
586 HEPATIC CYTOLYSIS 21 0.0016
587 TREATMENT FAILURE 134 0.0016
588 SUDDEN DEATH 17 0.0016
589 SKIN INFECTION 18 0.0016
590 HEPATIC CIRRHOSIS 30 0.0016
591 SARS-COV-2 TEST POSITIVE 21 0.0016
592 HAEMOGLOBIN DECREASED 163 0.0016
593 EPISTAXIS 118 0.0016
594 OFF LABEL USE 1375 0.0016
595 DISSEMINATED INTRAVASCULAR COAGULATION 22 0.0016
596 NEUTROPHIL COUNT INCREASED 16 0.0016
597 INFECTION 226 0.0016
598 COVID-19 273 0.0016
599 LEUKOCYTOSIS 28 0.0015
600 HYPERBILIRUBINAEMIA 16 0.0015
601 HEPATITIS ACUTE 10 0.0015
602 SPLENOMEGALY 18 0.0015
603 PULMONARY HAEMORRHAGE 12 0.0015
604 BRAIN NEOPLASM 14 0.0015
605 BLOOD THYROID STIMULATING HORMONE INCREASED 14 0.0015
606 FURUNCLE 12 0.0015
607 CHRONIC KIDNEY DISEASE 115 0.0015
608 ISCHAEMIC STROKE 27 0.0015
609 BLOOD CALCIUM DECREASED 17 0.0015
610 LYMPHADENOPATHY 53 0.0015
611 CHOLECYSTITIS CHRONIC 10 0.0015
612 BLOOD PRESSURE DIASTOLIC DECREASED 11 0.0015
613 STAPHYLOCOCCAL INFECTION 49 0.0015
614 DERMATITIS 31 0.0015
615 ABNORMAL LOSS OF WEIGHT 10 0.0015
616 CLOSTRIDIUM DIFFICILE INFECTION 32 0.0015
617 WEIGHT DECREASED 409 0.0015
618 SUPRAVENTRICULAR TACHYCARDIA 14 0.0015
619 BLOOD GLUCOSE ABNORMAL 27 0.0015
620 PULMONARY FIBROSIS 28 0.0015
621 SEIZURE 167 0.0014
622 LARGE INTESTINE POLYP 10 0.0014
623 HYPERTENSIVE CRISIS 16 0.0014
624 INFLAMMATORY BOWEL DISEASE 14 0.0014
625 HEPATOMEGALY 14 0.0014
626 THERAPY CESSATION 73 0.0014
627 MALIGNANT MELANOMA 19 0.0014
628 RENAL PAIN 15 0.0014
629 DRUG-INDUCED LIVER INJURY 44 0.0014
630 HEPATIC STEATOSIS 26 0.0014
631 SHOCK 32 0.0014
632 ELECTROCARDIOGRAM QT PROLONGED 50 0.0014
633 BLOOD PRESSURE INCREASED 212 0.0014
634 CENTRAL NERVOUS SYSTEM LESION 19 0.0014
635 VIRAL INFECTION 46 0.0014
636 NODULE 18 0.0014
637 EYELID OEDEMA 16 0.0014
638 MOTOR DYSFUNCTION 14 0.0014
639 RENAL DISORDER 64 0.0014
640 BLOOD CHOLESTEROL INCREASED 64 0.0014
641 NAIL DISORDER 12 0.0014
642 MENTAL STATUS CHANGES 38 0.0014
643 RHABDOMYOLYSIS 57 0.0014
644 DISEASE RECURRENCE 65 0.0014
645 MELAENA 30 0.0014
646 COUGH 381 0.0014
647 BLOOD PRESSURE ABNORMAL 27 0.0014
648 ABDOMINAL PAIN 313 0.0013
649 PLATELET COUNT DECREASED 143 0.0013
650 PRODUCTIVE COUGH 64 0.0013
651 NEOPLASM MALIGNANT 89 0.0013
652 GASTRITIS 35 0.0013
653 ACUTE MYOCARDIAL INFARCTION 39 0.0013
654 HEMIPLEGIA 11 0.0013
655 ABSCESS 21 0.0013
656 END STAGE RENAL DISEASE 24 0.0013
657 HYPERKALAEMIA 46 0.0013
658 VOMITING 615 0.0013
659 SKIN PLAQUE 11 0.0013
660 GLOSSODYNIA 29 0.0013
661 AGRANULOCYTOSIS 24 0.0013
662 SUBARACHNOID HAEMORRHAGE 13 0.0013
663 INTESTINAL OBSTRUCTION 48 0.0013
664 LEUKAEMIA 12 0.0013
665 OSTEOMYELITIS 23 0.0013
666 GENERALISED TONIC-CLONIC SEIZURE 21 0.0013
667 CEREBRAL INFARCTION 31 0.0013
668 BLOOD ALBUMIN DECREASED 10 0.0013
669 ASTHENIA 468 0.0012
670 REBOUND EFFECT 14 0.0012
671 FLUID OVERLOAD 18 0.0012
672 CELLULITIS 62 0.0012
673 GOUT 22 0.0012
674 HAEMATEMESIS 31 0.0012
675 GASTRIC ULCER 23 0.0012
676 DIABETIC KETOACIDOSIS 29 0.0012
677 DEEP VEIN THROMBOSIS 78 0.0012
678 OSTEOPENIA 18 0.0012
679 HERPES ZOSTER 68 0.0012
680 HEPATIC ENZYME INCREASED 80 0.0012
681 DYSPNOEA 664 0.0012
682 RESPIRATORY DISORDER 35 0.0012
683 TENDERNESS 12 0.0012
684 UPPER RESPIRATORY TRACT INFECTION 53 0.0011
685 EOSINOPHILIA 20 0.0011
686 ULCER 18 0.0011
687 PAIN IN JAW 32 0.0011
688 BODY TEMPERATURE DECREASED 11 0.0011
689 CIRCULATORY COLLAPSE 19 0.0011
690 BLOOD BILIRUBIN INCREASED 30 0.0011
691 FATIGUE 863 0.0011
692 NEUROPATHY PERIPHERAL 104 0.0011
693 AMENORRHOEA 19 0.0011
694 NEUTROPHIL COUNT DECREASED 44 0.0011
695 RASH MACULO-PAPULAR 24 0.0011
696 GASTROINTESTINAL HAEMORRHAGE 90 0.0011
697 DIABETES MELLITUS INADEQUATE CONTROL 19 0.0011
698 DIARRHOEA HAEMORRHAGIC 10 0.0011
699 CORONARY ARTERY DISEASE 32 0.0011
700 PRODUCT PRESCRIBING ISSUE 23 0.0011
701 GASTROENTERITIS VIRAL 19 0.0011
702 RED BLOOD CELL COUNT DECREASED 30 0.0010
703 PELVIC PAIN 19 0.0010
704 LETHARGY 60 0.0010
705 THERAPEUTIC RESPONSE DECREASED 62 0.0010
706 HAEMATOCRIT DECREASED 20 0.0010
707 PREMATURE DELIVERY 16 0.0010
708 FUNGAL INFECTION 33 0.0010
709 NAUSEA 782 0.0010
710 ABDOMINAL DISTENSION 103 0.0010
711 FEEDING DISORDER 20 0.0010
712 DELIRIUM 34 0.0010
713 HYPERTHYROIDISM 14 0.0010
714 MYOCARDIAL ISCHAEMIA 11 0.0010
715 DRY MOUTH 78 0.0010
716 SKIN DISORDER 32 0.0010
717 GASTRIC HAEMORRHAGE 11 0.0010
718 PANCREATITIS 50 0.0009
719 TOOTH DISORDER 21 0.0009
720 IMMUNODEFICIENCY 14 0.0009
721 ABDOMINAL PAIN UPPER 191 0.0009
722 PNEUMONIA ASPIRATION 23 0.0009
723 MEDICATION ERROR 51 0.0009
724 SINUS TACHYCARDIA 13 0.0009
725 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 65 0.0009
726 CYSTITIS 29 0.0009
727 ACNE 69 0.0009
728 GASTROINTESTINAL PAIN 10 0.0009
729 CARDIOGENIC SHOCK 13 0.0009
730 BLOOD POTASSIUM DECREASED 27 0.0009
731 DYSURIA 33 0.0009
732 THROMBOSIS 72 0.0009
733 DEATH 766 0.0009
734 HOSPITALISATION 136 0.0009
735 HYPOTENSION 177 0.0009
736 IMPAIRED GASTRIC EMPTYING 12 0.0009
737 DYSPHONIA 51 0.0009
738 GASTROINTESTINAL DISORDER 78 0.0009
739 RASH 379 0.0009
740 PREMATURE BABY 26 0.0009
741 CONJUNCTIVITIS 16 0.0009
742 CHILLS 101 0.0009
743 MUSCULOSKELETAL PAIN 45 0.0009
744 FLATULENCE 48 0.0008
745 BACK PAIN 196 0.0008
746 THYROID DISORDER 13 0.0008
747 PARALYSIS 12 0.0008
748 CEREBRAL HAEMORRHAGE 30 0.0008
749 NIGHT SWEATS 27 0.0008
750 MENINGIOMA 13 0.0008
751 HEPATIC CANCER 20 0.0008
752 LOCALISED INFECTION 20 0.0008
753 CONSTIPATION 180 0.0008
754 PRODUCT USE ISSUE 155 0.0008
755 CHEST PAIN 151 0.0008
756 DYSPHAGIA 77 0.0008
757 HAIR COLOUR CHANGES 10 0.0008
758 BLOOD CREATINE PHOSPHOKINASE INCREASED 23 0.0008
759 CYTOKINE RELEASE SYNDROME 16 0.0008
760 INFLAMMATION 41 0.0008
761 MANIA 13 0.0008
762 PHOTOSENSITIVITY REACTION 13 0.0008
763 BREAST CANCER FEMALE 21 0.0008
764 DRUG PRESCRIBING ERROR 15 0.0008
765 DRUG INEFFECTIVE 1021 0.0008
766 TOOTHACHE 14 0.0008
767 BLISTER 43 0.0008
768 DIVERTICULITIS 21 0.0008
769 RENAL CANCER 36 0.0008
770 WHITE BLOOD CELL COUNT DECREASED 81 0.0007
771 CONDITION AGGRAVATED 224 0.0007
772 DIPLOPIA 19 0.0007
773 POST PROCEDURAL COMPLICATION 14 0.0007
774 PULMONARY HYPERTENSION 15 0.0007
775 WOUND 20 0.0007
776 MASS 10 0.0007
777 PERIPHERAL SWELLING 110 0.0007
778 COMA 34 0.0007
779 TYPE 2 DIABETES MELLITUS 24 0.0007
780 LYMPHOMA 11 0.0007
781 BLOOD PRESSURE FLUCTUATION 17 0.0007
782 DELUSION 11 0.0007
783 HEPATOCELLULAR INJURY 10 0.0007
784 RASH PRURITIC 38 0.0007
785 OSTEONECROSIS 23 0.0007
786 LIVER INJURY 17 0.0007
787 BODY TEMPERATURE INCREASED 14 0.0007
788 URINARY INCONTINENCE 20 0.0007
789 STEVENS-JOHNSON SYNDROME 15 0.0007
790 COLON CANCER 10 0.0007
791 CARDIOVASCULAR DISORDER 17 0.0007
792 HAEMORRHOIDS 13 0.0007
793 FREQUENT BOWEL MOVEMENTS 18 0.0007
794 LOWER RESPIRATORY TRACT INFECTION 30 0.0007
795 DYSGEUSIA 49 0.0007
796 OXYGEN SATURATION DECREASED 37 0.0007
797 OSTEOPOROSIS 27 0.0007
798 PERICARDITIS 11 0.0007
799 LIVER FUNCTION TEST INCREASED 14 0.0007
800 INTENTIONAL PRODUCT USE ISSUE 57 0.0007
801 PROCEDURAL PAIN 18 0.0006
802 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 19 0.0006
803 LACTIC ACIDOSIS 21 0.0006
804 BLOOD URINE PRESENT 12 0.0006
805 RIB FRACTURE 13 0.0006
806 APHASIA 19 0.0006
807 WHITE BLOOD CELL COUNT INCREASED 24 0.0006
808 OROPHARYNGEAL PAIN 57 0.0006
809 SWELLING FACE 40 0.0006
810 RASH ERYTHEMATOUS 29 0.0006
811 CARDIAC ARREST 50 0.0006
812 HAEMORRHAGE 63 0.0006
813 FAECES DISCOLOURED 13 0.0006
814 URINARY RETENTION 20 0.0006
815 GAIT INABILITY 20 0.0006
816 ABDOMINAL PAIN LOWER 15 0.0006
817 ARRHYTHMIA 28 0.0006
818 BLOOD PRESSURE DECREASED 39 0.0006
819 HOT FLUSH 44 0.0006
820 BLOOD GLUCOSE INCREASED 110 0.0006
821 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 15 0.0006
822 DISORIENTATION 23 0.0006
823 ADVERSE DRUG REACTION 52 0.0006
824 TACHYCARDIA 51 0.0006
825 CARDIAC FAILURE CONGESTIVE 46 0.0006
826 ERUCTATION 11 0.0006
827 PRESCRIBED OVERDOSE 11 0.0006
828 PLASMA CELL MYELOMA 22 0.0006
829 EAR INFECTION 15 0.0006
830 RETCHING 12 0.0006
831 NASAL CONGESTION 33 0.0006
832 GALLBLADDER DISORDER 10 0.0006
833 RECTAL HAEMORRHAGE 24 0.0006
834 GLYCOSYLATED HAEMOGLOBIN INCREASED 14 0.0006
835 ATRIAL FIBRILLATION 54 0.0006
836 NERVOUS SYSTEM DISORDER 17 0.0005
837 LABORATORY TEST ABNORMAL 16 0.0005
838 SYNCOPE 54 0.0005
839 RENAL INJURY 16 0.0005
840 ALOPECIA 103 0.0005
841 DRY SKIN 70 0.0005
842 ILLNESS 54 0.0005
843 SWELLING 49 0.0005
844 AGEUSIA 13 0.0005
845 HERNIA 10 0.0005
846 ECZEMA 27 0.0005
847 PALLOR 14 0.0005
848 FLUID RETENTION 26 0.0005
849 LIP SWELLING 17 0.0005
850 KIDNEY INFECTION 10 0.0005
851 GASTROOESOPHAGEAL REFLUX DISEASE 41 0.0005
852 PRURITUS GENERALISED 11 0.0005
853 ALTERED STATE OF CONSCIOUSNESS 11 0.0005
854 ERYTHEMA 104 0.0005
855 CARDIO-RESPIRATORY ARREST 21 0.0005
856 ABDOMINAL DISCOMFORT 84 0.0005
857 LACRIMATION INCREASED 15 0.0005
858 ARTHRALGIA 206 0.0005
859 MYALGIA 84 0.0005
860 PRURITUS 189 0.0005
861 TREMOR 81 0.0005
862 CONFUSIONAL STATE 78 0.0005
863 NEEDLE ISSUE 14 0.0005
864 DRY EYE 24 0.0005
865 VERTIGO 29 0.0005
866 DYSKINESIA 19 0.0005
867 ADVERSE EVENT 43 0.0005
868 GASTRIC DISORDER 16 0.0005
869 NECK PAIN 26 0.0005
870 MALAISE 204 0.0005
871 HEART RATE INCREASED 46 0.0005
872 RHINORRHOEA 30 0.0005
873 LUNG NEOPLASM MALIGNANT 19 0.0005
874 BLOOD GLUCOSE DECREASED 22 0.0005
875 SPEECH DISORDER 24 0.0005
876 PAIN 281 0.0005
877 INTERNATIONAL NORMALISED RATIO INCREASED 13 0.0005
878 DEPRESSED LEVEL OF CONSCIOUSNESS 18 0.0005
879 NEURALGIA 11 0.0005
880 PRODUCT SUBSTITUTION ISSUE 26 0.0005
881 MUSCULAR WEAKNESS 51 0.0004
882 INFLUENZA 50 0.0004
883 AGGRESSION 22 0.0004
884 BRONCHITIS 32 0.0004
885 MYOCARDIAL INFARCTION 75 0.0004
886 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 77 0.0004
887 HEART RATE DECREASED 15 0.0004
888 VISUAL ACUITY REDUCED 14 0.0004
889 INTENTIONAL DOSE OMISSION 12 0.0004
890 ANGINA PECTORIS 12 0.0004
891 HYPERSOMNIA 12 0.0004
892 FOETAL EXPOSURE DURING PREGNANCY 34 0.0004
893 DYSPEPSIA 41 0.0004
894 GAIT DISTURBANCE 78 0.0004
895 PSYCHOTIC DISORDER 12 0.0004
896 LIMB INJURY 11 0.0004
897 PAIN IN EXTREMITY 119 0.0004
898 EXPOSURE DURING PREGNANCY 25 0.0004
899 TREATMENT NONCOMPLIANCE 22 0.0004
900 OCULAR HYPERAEMIA 19 0.0004
901 HEADACHE 250 0.0004
902 FLUSHING 40 0.0004
903 CHEST DISCOMFORT 40 0.0004
904 PRODUCT DOSE OMISSION IN ERROR 11 0.0004
905 SWOLLEN TONGUE 12 0.0004
906 ACCIDENTAL OVERDOSE 14 0.0004
907 AGITATION 28 0.0004
908 MOOD SWINGS 12 0.0004
909 MOVEMENT DISORDER 12 0.0004
910 NEPHROLITHIASIS 17 0.0004
911 MATERNAL EXPOSURE DURING PREGNANCY 33 0.0004
912 LOSS OF CONSCIOUSNESS 47 0.0004
913 FALL 122 0.0004
914 BRADYCARDIA 19 0.0004
915 SKIN EXFOLIATION 30 0.0004
916 LIMB DISCOMFORT 11 0.0004
917 SLEEP DISORDER 25 0.0004
918 ABNORMAL BEHAVIOUR 14 0.0004
919 CARDIAC DISORDER 33 0.0004
920 SINUSITIS 36 0.0004
921 HYPOACUSIS 15 0.0003
922 MOBILITY DECREASED 25 0.0003
923 HEAD INJURY 11 0.0003
924 CATARACT 20 0.0003
925 IRRITABILITY 20 0.0003
926 DRUG EFFECT INCOMPLETE 12 0.0003
927 HAEMATOCHEZIA 18 0.0003
928 HYPERSENSITIVITY 60 0.0003
929 WEIGHT INCREASED 72 0.0003
930 WHEEZING 19 0.0003
931 BLINDNESS 13 0.0003
932 DYSARTHRIA 12 0.0003
933 CEREBROVASCULAR ACCIDENT 53 0.0003
934 HIP FRACTURE 10 0.0003
935 SKIN DISCOLOURATION 14 0.0003
936 DEPRESSION 69 0.0003
937 DIZZINESS 149 0.0003
938 EYE SWELLING 11 0.0003
939 INSOMNIA 78 0.0003
940 COLITIS ULCERATIVE 13 0.0003
941 VISUAL IMPAIRMENT 36 0.0003
942 SURGERY 17 0.0003
943 JOINT SWELLING 35 0.0003
944 POLLAKIURIA 12 0.0003
945 PRODUCT DOSE OMISSION ISSUE 83 0.0003
946 CONVULSION 16 0.0003
947 DISCOMFORT 17 0.0003
948 ANAPHYLACTIC REACTION 15 0.0003
949 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 13 0.0003
950 INFLUENZA LIKE ILLNESS 22 0.0003
951 PARAESTHESIA 42 0.0003
952 PALPITATIONS 31 0.0003
953 SOMNOLENCE 53 0.0003
954 CONTUSION 25 0.0003
955 ASTHMA 29 0.0003
956 MENTAL DISORDER 11 0.0003
957 HYPERHIDROSIS 32 0.0002
958 NASOPHARYNGITIS 45 0.0002
959 MUSCLE SPASMS 43 0.0002
960 HYPOAESTHESIA 35 0.0002
961 COLORECTAL CANCER 11 0.0002
962 BURNING SENSATION 16 0.0002
963 BALANCE DISORDER 19 0.0002
964 OVERDOSE 47 0.0002
965 AMNESIA 14 0.0002
966 DEPRESSED MOOD 11 0.0002
967 VISION BLURRED 28 0.0002
968 PROSTATE CANCER 16 0.0002
969 ILL-DEFINED DISORDER 12 0.0002
970 EYE PAIN 11 0.0002
971 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 10 0.0002
972 NERVOUSNESS 10 0.0002
973 ANXIETY 54 0.0002
974 INTENTIONAL PRODUCT MISUSE 16 0.0002
975 MUSCULOSKELETAL STIFFNESS 16 0.0002
976 NO ADVERSE EVENT 33 0.0002
977 FEELING HOT 11 0.0002
978 FEELING ABNORMAL 41 0.0002
979 MIGRAINE 16 0.0002
980 INFUSION RELATED REACTION 11 0.0002
981 ARTHRITIS 13 0.0002
982 HALLUCINATION 12 0.0002
983 INJURY 11 0.0002
984 MEMORY IMPAIRMENT 21 0.0002
985 UNEVALUABLE EVENT 11 0.0001
986 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 29 0.0001
987 INCORRECT DOSE ADMINISTERED 32 0.0001
988 URTICARIA 22 0.0001
989 PSORIASIS 12 0.0001
990 DRUG DEPENDENCE 14 0.0001
991 INJECTION SITE PAIN 21 0.0001